Related Experiment Video
Updated: May 21, 2025
A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection
Published on: August 14, 2019
The Epidemiology and Burden of Human Parainfluenza Virus Hospitalizations in US Children
Geoffrey A Weinberg1, Annabelle M de St Maurice2, Yasmeen Z Qwaider3
1Department of Pediatrics, University of Rochester School of Medicine and Dentistry, and UR-Golisano Children's Hospital, Rochester, NY, USA.
Insights
Human parainfluenza virus (PIV) hospitalizations are a significant concern for young children. Focusing prevention on infants and specific PIV types like PIV-3, PIV-1, and PIV-4 could reduce hospitalizations.
Area of Science:
- Pediatric Infectious Diseases
- Respiratory Virology
- Public Health Surveillance
Background:
- Human parainfluenza viruses (PIV) are a leading cause of acute respiratory infections (ARI) requiring hospitalization in young children.
- Understanding PIV burden and characteristics is crucial for developing effective interventions.
Purpose of the Study:
- To quantify the burden of PIV hospitalizations in children.
- To characterize children hospitalized with PIV by virus type.
Main Methods:
- Utilized data from the New Vaccine Surveillance Network (2016-2020).
- Included prospective, population-based surveillance of children hospitalized for ARI at 7 U.S. children's hospitals.
- Analyzed demographic, clinical, and virologic data (RT-PCR); calculated hospitalization rates by age and PIV type.
Main Results:
- Of 702 children with PIV detected as the sole virus, 48% had comorbidities and 20% had a history of prematurity.
- Hospitalization rates were highest in infants aged 0-5 months (1.91/1000/year).
- PIV-3, PIV-1, and PIV-4 contributed significantly to hospitalizations in this age group.
Conclusions:
- PIV infection significantly contributes to ARI hospitalizations in infants.
- Future prevention strategies targeting younger children and specific PIV types (PIV-3, PIV-1, PIV-4) may reduce hospitalization burden.
Background:
Human parainfluenza viruses (PIV) are a major cause of acute respiratory infection (ARI) leading to hospitalization in young children. In order to quantify the burden of PIV hospitalizations and to evaluate the characteristics of children hospitalized with PIV by virus type, we used data from the New Vaccine Surveillance Network, a multicenter, active, prospective population-based surveillance network, enrolling children hospitalized for ARI (defined as fever and/or respiratory symptoms) at 7 U.S. children's hospitals.
Methods:
The study period included December 1, 2016 through March 31, 2020. Data captured included demographic characteristics, clinical presentation, underlying medical conditions, discharge diagnoses, and virus detection by RT-PCR. Linear and logistic regression were used to compare descriptive and clinical characteristics among children. Population-based PIV-associated hospitalization rates were calculated by age group and PIV-type.
Results:
Of the 16,971 enrolled children with PIV virologic testing, 10,488 had only one respiratory virus detected, among whom 702 (7%) had positive testing for PIV without a co-detected virus (mean age [SD], 2.2 [3.2] years). Of these 702 children, 340 (48%) had underlying comorbidities, 139 (20%) had a history of prematurity, 121 (17%) were admitted to the ICU, and 23 (3%) required intubation. Overall, PIV hospitalization rates were highest in children aged 0-5 months, 1.91 hospitalizations per 1,000 children per year [95% CI, 1.61-2.23]; PIV-3 contributed to the highest rates in that age group, followed by PIV-1 and PIV-4: 1.08 [0.84-1.21], 0.42 [0.28-0.58] and 0.25 [0.15-0.37] per 1,000 children per year, respectively. Seasonal distribution of PIV-associated hospitalizations varied by type.
Conclusions:
PIV infection was associated with a substantial number of ARI hospitalizations in children aged 0-5 months. Results suggest that future PIV prevention strategies in the US that focus on younger children and protection against PIV-3, PIV-1, and PIV-4 might have the greatest impact on reducing PIV hospitalization burden.
Related Concept Videos
01:51Vaccinations
00:36Viral Mutations
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...